Login  |  Register

Ibrutinib: A Look into Its Market Penetration and Future Prospects

Ibrutinib is a medicine that inhibits Bruton's tyrosine kinase (BTK), a protein essential for the proliferation of cancer cells, to effectively treat certain blood malignancies.